Targeted Microbiome Intervention by Microencapsulated Delayed-Release Niacin Beneficially Affects Insulin Sensitivity in Humans.

Daniela FangmannEva-Maria TheismannKathrin TürkDominik M SchulteIsabelle RellingKatharina HartmannJulia K KepplerJörg-Rainer KnippAteequr RehmanFemke-Anouska HeinsenAndre FrankeLennart LenkSandra Freitag-WolfEsther AppelStanislav GorbCharles BrennerDirk SeegertGeorg H WaetzigPhilip RosenstielStefan SchreiberKarin SchwarzMatthias Laudes

Published in: Diabetes care (2017)

Targeted microbiome intervention by delayed-release NA might represent a future therapeutic option for prediabetes and type 2 diabetes.

Keyphrases

type diabetes
randomized controlled trial
cancer therapy
cardiovascular disease
glycemic control